Dietary fat attenuates the benefits of an elemental diet in active Crohn's disease
Authors:
- Takashi ShimoyamaTSTakashi Shimoyama
- Masaya SasakiMSMasaya Sasaki
- Tomoyuki TsujikawaTTTomoyuki Tsujikawa
- Yoshihiro FukudaYFYoshihiro Fukuda
- Kazutaka KoganeiKKKazutaka Koganei
- Toshifumi HibiTHToshifumi Hibi
- Yasushi IwaoYIYasushi Iwao
- Akihiro MunakataAMAkihiro Munakata
- Shinsaku FukudaSFShinsaku Fukuda
- Takayuki MatsumotoTMTakayuki Matsumoto
- Nobuhide OshitaniNONobuhide Oshitani
- 1 February 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 15 (2) , 151-157
Abstract
Although an elemental diet has been established as the primary treatment for patients with Crohn's disease, the influence of dietary fat on the elemental diet remains unclear. We have designed the first randomized, controlled trial for elemental diets containing different fat percentages in patients with active Crohn's disease. Each patient was randomized to receive one of three dose levels of fat in an elemental diet (Elental) for 4 weeks: 10 patients received low fat (3.06 g/day), 10 patients received medium fat (16.56 g/day) and eight patients received high fat (30.06 g/day). The additional fat was composed of long-chain fatty acids. All patients were evaluated using the International Organization of Inflammatory Bowel Disease rating, plus C-reactive protein level and erythrocyte sedimentation rate, which were measured at weekly intervals. Although the International Organization of Inflammatory Bowel Disease rating, C-reactive protein level and erythrocyte sedimentation rate in the low-fat group decreased, the values in the medium- and high-fat groups fluctuated during the study. The remission rate after 4 weeks in each group was 80%, 40% and 25% for patients in the low-, medium- and high-fat groups, respectively. When the fat consisted of long-chain triglycerides, a high amount of this fat in the elemental diet formula decreased its therapeutic effect against active Crohn's disease.Keywords
This publication has 26 references indexed in Scilit:
- Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trialAmerican Journal of Gastroenterology, 2000
- Nutritional Therapy in Crohnʼs DiseaseInflammatory Bowel Diseases, 1998
- A randomized controlled study comparing elemental diet and steroid treatment in Crohn's diseaseAlimentary Pharmacology & Therapeutics, 1997
- Enteral nutrition as primary therapy in Crohn's disease.Gut, 1994
- Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone.Gut, 1993
- Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.Gut, 1993
- Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet.Gut, 1991
- Enteral feeding as sole treatment for Crohn's disease: controlled trial of whole protein v amino acid based feed and a case study of dietary challenge.Gut, 1991
- Controlled trial of polymeric versus elemental diet in treatment of active Crohn's diseaseThe Lancet, 1990
- Elemental diet as primary treatment of acute Crohn's disease: a controlled trial.BMJ, 1984